Malaria drug fails to prevent COVID-19 in a rigorous study

A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

The COPCOV Trial's position statement on “A living WHO guideline on drugs to prevent COVID-19.” — MORU Tropical Health Network

More deaths, no benefit from malaria drug in VA virus study

Malaria - The Lancet

In-line treatments and clinical initiatives to fight against COVID-19 outbreak - ScienceDirect

2022 Archive - New Genomic Research Shows Why Testing Malaria Vaccines in the Clinic is as Rigorous as Natural Exposure in the Field

US hospitals slash use of drug championed by Donald Trump as coronavirus treatment

Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

Searching for an effective Covid-19 treatment: promise and peril - STAT

Chloroquine for COVID-19: rationale, facts, hopes, Critical Care

Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications

How Close Are We to Finding a Treatment for COVID-19?